Last updated on April 2018

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC


Brief description of study

Primary end points:

This clinical trial is aimed to analyze the effectiveness of Levonorgestrel-Releasing Intrauterine System (LNG-IUS, Mirena) in the fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma, including pathology response and pregnancy outcome.

Second end points:

To analyze the appearances of side-effects.

Clinical Study Identifier: NCT03463252

Find a site near you

Start Over